BattinoD, TomsonT, BonizzoniE, EURAP Collaborators. et al.; Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy. JAMA Neurol2024;81(5):481–489.
2.
Hernandez-DiazS, QuinnM, ConantS, et al.Use of Antiseizure Medications Early in Pregnancy and the Risk of Major Malformations in the Newborn. Neurology2025;105(3):e213786.
3.
PennellPB, FrenchJA, MayRC, MONEAD Study Group. et al.; Changes in Seizure Frequency and Antiepileptic Therapy during Pregnancy. N Engl J Med2020;383(26):2547–2556.
4.
VoinescuEP, EhlertAN, BayCP, et al.Variations in Seizure Frequency During Pregnancy and Postpartum by Epilepsy Type. Neurology2022;98(8):e802–e807; doi: 10.1212/WNL.0000000000013056
5.
DarmawanKF, LeonardSA, MeadorKJ, et al.Increased primary cesarean births among people with epilepsy: A population-based cohort study. Journal of Women’s Health2026;35(6):525–531; doi: 10.1177/15409996251405047
6.
Berry-NoronhaA, ManoleehakulP, RottlerA, et al.Risk of adverse pregnancy outcomes associated with antiseizure medications and their indications. Neurology2025;104(3):e210233.
7.
MazzonePP, HoggKM, WeirCJ, et al.Comparison of perinatal outcomes for women with and without epilepsy. JAMA Neurol2023;80(5):484–494.
8.
McElrathTF, et al.The obstetrical care and delivery experience of women with epilepsy in the MODEAD study. Am J Perinat2022; doi: 10.1055/a-1788-4791
